Pharmaceutical

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.

Oct 20, 2024 - 04:00
TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.
Read the original article

Tags:

Previous Article

mRNA licensing agreements surge 800% amid GSK lawsuits

Next Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

SGNB-7H4V by Pfizer for Peritoneal Cancer: Likelihood of Approval

SGNB-7H4V by Pfizer for Peritoneal Cancer: Likelihood o...

Jun 20, 2024

Listen: VC turmoil, GLP-1 competition, & the war on recovery

Listen: VC turmoil, GLP-1 competition, & the war on rec...

Mar 8, 2024

ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer

ImmunoPrecise and Biotheus partner on bispecific antibo...

Oct 4, 2024